posted on 2019-10-14, 10:28authored byC. Nestor, S. Nasim, N. Coyle, C. Canavan
Metformin is considered the first line oral hypoglycaemic agent for the treatment of type 2 diabetes. We report three cases of prospectively identified laboratory confirmed metformin-associated lactic acidosis admitted to our intensive care unit.